Reactive oxygen species-mediated p53 core-domain modifications determine apoptotic or necrotic death in cancer cells

Rajan Gogna1, Esha Madan, Periannan Kuppusamy

  • 1Transcription and Human Biology Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.

Abstract

Insights

Gold nanoparticles (Au-NPs) trigger p53-dependent apoptosis and necrosis in cancer cells. Differential reactive oxygen species (ROS) patterns dictate p53 modifications, leading to distinct downstream gene activation and tumor regression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Nanotechnology

Background:

  • The tumor suppressor p53 plays a critical role in cellular stress responses, inducing apoptosis or necrosis.
  • The precise molecular mechanisms governing p53's choice between apoptotic and necrotic cell death pathways remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying p53's decision to induce either apoptosis or necrosis.
  • To investigate the role of gold nanoparticles (Au-NPs) in modulating p53-mediated cell death pathways.

Main Methods:

  • Utilized gold nanoparticles (Au-NPs) to induce cell death in cancer cells.
  • Analyzed differential reactive oxygen species (ROS) generation patterns.
  • Assessed p53 post-translational modifications (phosphorylation and acetylation) and DNA-binding activity.
  • Quantified the activation of distinct sets of p53-downstream genes.
  • Evaluated tumor regression in a mouse xenograft model.

Main Results:

  • Au-NPs induced both apoptosis and necrosis in a p53-dependent manner.
  • Differential ROS generation correlated with distinct p53 post-translational modification patterns (core-domain for apoptosis, N- and C-termini for necrosis).
  • Specific Au-NP formulations (Au-NP10 and Au-NP80) activated distinct sets of apoptotic and necrotic p53-downstream genes.
  • Both Au-NP formulations demonstrated significant tumor regression in HCT (p53+/+) xenografts.

Conclusions:

  • Au-NP-mediated p53 activation, modulated by ROS and distinct post-translational modification patterns, drives tumor regression via both apoptotic and necrotic pathways.
  • This highlights the potential of nanoparticles in cancer therapy by targeting specific p53-mediated cell death mechanisms.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...